doctors are worried about prescribing glp 1 GLP-1 obesity drugs and eating disorders not well understood yet : NPR Millions of people are taking

Trends in FDA FY2024 Inspection-Based Warning Letters, supra note 3

Label Ingredients: bulking agent (microcrystalline cellulose), reduced L-glutathione, anti-caking agents (vegetable magnesium stearate), glazing agents (ethyl cellulose, ammonium hydroxide, medium chain triglycerides, oleic acid, sodium alginate, stearic acid).

In addition, multiple inflammatory signaling cascades, including the JAKSTAT pathway, participate in ferroptosisinflammation interactions (61)

Some restaurateurs say flexibility not smaller offerings is the real trend

Liu P, Wu D, Duan J, Xiao H, Zhou Y, Zhao L, et al

Proteomic analyses from the STEP weight loss trials in people with or without T2D revealed semaglutide-induced changes in inflammatory and immune regulatory pathways that could not be fully attributed to metabolic improvements alone (25)